The potential role of nicotinamide on Leishmania tropica: An assessment of inhibitory effect, cytokines gene expression and arginase profiling.


Journal

International immunopharmacology
ISSN: 1878-1705
Titre abrégé: Int Immunopharmacol
Pays: Netherlands
ID NLM: 100965259

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 20 04 2020
revised: 30 05 2020
accepted: 11 06 2020
pubmed: 27 6 2020
medline: 29 5 2021
entrez: 27 6 2020
Statut: ppublish

Résumé

Leishmaniasis represents a major health concern worldwide which has no effective treatment modality. Nicotinamide (NAm) has been used for a wide range of applications from anticancer to antimicrobial usage. This study aimed to assess the effect of NAm combination on Leishmania tropica Inhibition, as well as on cytokines gene expression and arginase (ARG) activity in L. tropica-infected macrophages in an in vitro model. The leishmanicidal effects of NAm and Glucantime (meglumine antimoniate, MA) alone and in combination (NAm/MA) were evaluated using a colorimetric assay and macrophage model. Additionally, immunomodulatory effects and enzymatic activity were assessed by analyzing Th1 and Th2 cytokines gene expression and ARG level, respectively, in infected macrophages treated with NAm and MA, alone and in combination. Findings indicated that the NAm/MA combination demonstrated greater inhibitory effects on L. tropica promastigotes and amastigotes compared with each drug individually. Docking results proved the affinity of NAm to IFN-γ, which can affirm the increased levels of IFN-γ, IL-12p40 and TNF-α as well as reductions in IL-10 secretion with a dose-response effect, especially in the combination group. The NAm/MA combination also showed a significant reduction in the level of ARG activity at all concentrations used compared to each drug individually. These findings indicate higher effectiveness of NAm plus MA in reducing parasite growth, promoting immune response and inhibiting ARG level. This combination should be considered as a potential therapeutic regimen for treatment of volunteer patients with anthroponotic cutaneous leishmaniasis (ACL) in future control programs.

Identifiants

pubmed: 32590317
pii: S1567-5769(20)31212-1
doi: 10.1016/j.intimp.2020.106704
pii:
doi:

Substances chimiques

Antiprotozoal Agents 0
Cytokines 0
Niacinamide 25X51I8RD4
Meglumine Antimoniate 75G4TW236W
Arginase EC 3.5.3.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106704

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Razieh Tavakoli Oliaee (RT)

Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran; Basic Sciences in Infectious Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Iraj Sharifi (I)

Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran. Electronic address: iraj.sharifi@yahoo.com.

Mehdi Bamorovat (M)

Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran.

Alireza Keyhani (A)

Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran.

Zahra Babaei (Z)

Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran.

Ehsan Salarkia (E)

Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran.

Rahele Tavakoly (R)

Student Research Committee, School of Health, Kerman University of Medical Sciences, Kerman, Iran; Nutrition Research Center, School of Nutrition and Food Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.

Ahmad Khosravi (A)

Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran.

Mahshid Mostafavi (M)

Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran.

Fatemeh Sharifi (F)

Research Center of Tropical and Infectious Diseases, Kerman University of Medical Sciences, Kerman, Iran.

Seyed Mohammad Mousavi (SM)

Research Center for Hydatid Disease in Iran, Kerman University of Medical Sciences, Kerman, Iran.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH